S. Leckie

Patients with immunological diseases or on peritoneal dialysis are prone to false positive flow cytometry crossmatch.

A. House, L. Gunaratnam, A. Jevnikar, 2019, Human immunology.

Angiotensin II type I receptor agonistic autoantibodies are associated with poor allograft survival in liver retransplantation

A. House, Vivian Charles McAlister, P. Marotta, 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Autoantibodies to LG3 are associated with poor long‐term survival after liver retransplantation

A. House, M. Molinari, A. Zeevi, 2021, Clinical transplantation.

Re-exposure to Mismatched HLA Class I Is a Significant Risk Factor for Graft Loss: Multivariable Analysis of 259 Kidney Retransplants

F. Rehman, A. House, A. Jevnikar, 2007, Transplantation.

Epstein-Barr virus seronegativity is a risk factor for late-onset posttransplant lymphoroliferative disorder in adult renal allograft recipients1

V. Shahinian, A. House, A. Jevnikar, 2003 .

Epstein-Barr virus seronegativity is a risk factor for late-onset posttransplant lymphoroliferative disorder in adult renal allograft recipients.

V. Shahinian, A. House, A. Jevnikar, 2003, Transplantation.

The impact of allograft nephrectomy on percent panel reactive antibody and clinical outcome.

V. Shahinian, A. House, A. Jevnikar, 2003, Transplantation proceedings.

The impact of alloantibodies directed against the second donor on long-term outcomes of repeat liver transplantation.

Bradly Shrum, A. Skaro, Qingyong Xu, 2019, Hepatobiliary surgery and nutrition.

Defective KIM-1 phagocytosis does not predispose to acute graft dysfunction after kidney transplantation in humans.

R. Hegele, A. McIntyre, L. Gunaratnam, 2022, Kidney international.

The importance of class I and class II HLA in cadaveric renal transplantation.

Truls Østbye, W. Howson, F. Sutherland, 1991, Clinical and investigative medicine. Medecine clinique et experimentale.